| Targeting T cell metabolism for improvement of cancer immunotherapy T Le Bourgeois, L Strauss, HI Aksoylar, S Daneshmandi, P Seth, ... Frontiers in oncology 8, 237, 2018 | 174 | 2018 |
| Blockade of lactate dehydrogenase-A (LDH-A) improves efficacy of anti-programmed cell death-1 (PD-1) therapy in melanoma S Daneshmandi, B Wegiel, P Seth Cancers 11 (4), 450, 2019 | 138 | 2019 |
| Metabolic switch in the tumor microenvironment determines immune responses to anti-cancer therapy B Wegiel, M Vuerich, S Daneshmandi, P Seth Frontiers in oncology 8, 284, 2018 | 109 | 2018 |
| Immunomodulatory effect of Parsley (Petroselinum crispum) essential oil on immune cells: Mitogen-activated splenocytes and peritoneal macrophages A Yousofi, S Daneshmandi, N Soleimani, K Bagheri, MH Karimi Immunopharmacology and Immunotoxicology 34 (2), 303-308, 2012 | 78 | 2012 |
| Cytokine gene polymorphism and asthma susceptibility, progress and control level S Daneshmandi, AA Pourfathollah, Z Pourpak, H Heidarnazhad, ... Molecular biology reports 39, 1845-1853, 2012 | 73 | 2012 |
| The Role of Lactate Metabolism in Prostate Cancer Progression and Metastases Revealed by Dual-Agent Hyperpolarized 13C MRSI R Bok, J Lee, R Sriram, K Keshari, S Sukumar, S Daneshmandi, ... Cancers 11 (2), 257, 2019 | 62 | 2019 |
| Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes A Singh, S Ramachandran, ML Graham, S Daneshmandi, D Heller, ... Nature communications 10 (1), 3495, 2019 | 59 | 2019 |
| Immunomodulatory effects of clove (Syzygium aromaticum) constituents on macrophages: In vitro evaluations of aqueous and ethanolic components SP Dibazar, S Fateh, S Daneshmandi Journal of immunotoxicology 12 (2), 124-131, 2015 | 55 | 2015 |
| Non-association of IL-12+ 1188 and IFN-γ+ 874 polymorphisms with cytokines serum level in occult HBV infected patients MK Arababadi, AA Pourfathollah, A Jafarzadeh, G Hassanshahi, ... Saudi Journal of Gastroenterology 17 (1), 30-35, 2011 | 54 | 2011 |
| EVALUATION OF RELATION BETWEEN IL-4 AND IFN-γ: POLYMORPHISMS AND TYPE 2 DIABETES AM Kazemi, EAA POURFATH, S Daneshmandi, GHH HASANSHAHI, ... Iranian Journal of Basic Medical Sciences 12 (242), 100-104, 2009 | 49 | 2009 |
| A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients MH Karimi, S Daneshmandi, AA Pourfathollah, B Geramizadeh, ... Molecular Biology Reports 39, 509-515, 2012 | 47 | 2012 |
| Clove (Syzygium aromaticum) ingredients affect lymphocyte subtypes expansion and cytokine profile responses: An in vitro evaluation SP Dibazar, S Fateh, S Daneshmandi journal of food and drug analysis 22 (4), 448-454, 2014 | 45 | 2014 |
| Blockade of 6-phosphogluconate dehydrogenase generates CD8+ effector T cells with enhanced anti-tumor function S Daneshmandi, T Cassel, P Lin, RM Higashi, GM Wulf, VA Boussiotis, ... Cell reports 34 (10), 2021 | 44 | 2021 |
| Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients MT Tahoori, AA Pourfathollah, M Akhlaghi, S Daneshmandi, MH Nicknam, ... Clinical and Experimental Rheumatology-Incl Supplements 29 (5), 763, 2011 | 43 | 2011 |
| TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model S Daneshmandi, MH Karimi, AA Pourfathollah International immunopharmacology 44, 191-196, 2017 | 39 | 2017 |
| Association of IL-6 promoter and IFN-γ gene polymorphisms with acute rejection of liver transplantation MH Karimi, S Daneshmandi, AA Pourfathollah, B Geramizadeh, ... Molecular biology reports 38, 4437-4443, 2011 | 39 | 2011 |
| The effect of shark liver oil on the tumor infiltrating lymphocytes and cytokine pattern in mice M Hajimoradi, ZM Hassan, AA Pourfathollah, S Daneshmandi, ... Journal of Ethnopharmacology 126 (3), 565-570, 2009 | 37 | 2009 |
| Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients A Mohammadzadeh, AA Pourfathollah, MT Tahoori, S Daneshmandi, ... Rheumatology international 32, 2833-2836, 2012 | 30 | 2012 |
| 6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function S Daneshmandi, T Cassel, RM Higashi, TWM Fan, P Seth Elife 10, e67476, 2021 | 29 | 2021 |
| Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice S Shahrokhi, S Daneshmandi, F Menaa Human gene therapy 25 (3), 240-253, 2014 | 28 | 2014 |